We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Hemolysis in Blood Samples in the ER

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01815931
Recruitment Status : Completed
First Posted : March 21, 2013
Last Update Posted : November 11, 2013
Sponsor:
Information provided by (Responsible Party):
Olivier T. Rutschmann, University Hospital, Geneva

Brief Summary:
In this study, we aim to identify risk factors for hemolysis in blood samples drawn in the ED.

Condition or disease
Hemolysis Emergency Service, Hospital Emergencies Blood Specimen Collection

Study Type : Observational
Actual Enrollment : 2800 participants
Observational Model: Cohort
Time Perspective: Prospective
Study Start Date : June 2013
Primary Completion Date : October 2013
Study Completion Date : October 2013

Group/Cohort
ED patients



Primary Outcome Measures :
  1. Hemolysis rate [ Time Frame: 1 day ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   16 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All adult (> 16 y) patients admitted in the emergency departement during the study period
Criteria

Inclusion Criteria:

  • > 16 years

Exclusion Criteria:

  • In vivo hemolysis

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01815931


Locations
Switzerland
University Hospital, Geneva
Geneva, GE, Switzerland, 1211
Sponsors and Collaborators
University Hospital, Geneva

Responsible Party: Olivier T. Rutschmann, MD, MPH, University Hospital, Geneva
ClinicalTrials.gov Identifier: NCT01815931     History of Changes
Other Study ID Numbers: SU-032013
First Posted: March 21, 2013    Key Record Dates
Last Update Posted: November 11, 2013
Last Verified: November 2013

Additional relevant MeSH terms:
Emergencies
Hemolysis
Disease Attributes
Pathologic Processes